The purpose of this study is to test the safety and efficacy of repeated doses of ketamine as
compared to placebo, in reducing symptoms of Posttraumatic Stress Disorder (PTSD) in an
active duty military and Veteran population.
Phase:
Phase 2
Details
Lead Sponsor:
VA Office of Research and Development
Collaborators:
Brooke Army Medical Center Minneapolis Veterans Affairs Medical Center The University of Texas Health Science Center at San Antonio